Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium Price to Book Value : 1.438 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.438 |
| October 21, 2026 | 1.607 |
| October 20, 2026 | 1.562 |
| October 19, 2026 | 1.404 |
| October 16, 2026 | 1.347 |
| October 15, 2026 | 1.494 |
| October 14, 2026 | 1.472 |
| October 13, 2026 | 1.494 |
| October 12, 2026 | 1.698 |
| October 09, 2026 | 1.596 |
| October 08, 2026 | 1.63 |
| October 07, 2026 | 1.573 |
| October 06, 2026 | 1.607 |
| October 05, 2026 | 1.641 |
| October 02, 2026 | 1.596 |
| October 01, 2026 | 1.743 |
| September 30, 2026 | 1.839 |
| September 29, 2026 | 1.834 |
| September 28, 2026 | 1.902 |
| September 25, 2026 | 1.890 |
| September 24, 2026 | 1.947 |
| September 23, 2026 | 1.981 |
| September 22, 2026 | 2.185 |
| September 21, 2026 | 2.145 |
| September 18, 2026 | 2.173 |
| Date | Value |
|---|---|
| September 17, 2026 | 2.139 |
| September 16, 2026 | 2.100 |
| September 15, 2026 | 2.320 |
| September 14, 2026 | 2.372 |
| September 11, 2026 | 2.388 |
| September 10, 2026 | 2.739 |
| September 09, 2026 | 2.898 |
| September 08, 2026 | 2.728 |
| September 04, 2026 | 2.502 |
| September 03, 2026 | 2.513 |
| September 02, 2026 | 2.547 |
| September 01, 2026 | 2.496 |
| August 31, 2026 | 2.570 |
| August 28, 2026 | 2.705 |
| August 27, 2026 | 2.773 |
| August 26, 2026 | 2.671 |
| August 25, 2026 | 2.468 |
| August 24, 2026 | 2.490 |
| August 21, 2026 | 2.615 |
| August 20, 2026 | 2.570 |
| August 19, 2026 | 2.638 |
| August 18, 2026 | 2.660 |
| August 17, 2026 | 2.807 |
| August 14, 2026 | 2.671 |
| August 13, 2026 | 2.275 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.676 |
| Alnylam Pharmaceuticals, Inc. | 22.45 |
| Anika Therapeutics, Inc. | 2.056 |
| Savara, Inc. | 6.491 |
| Vericel Corp. | 5.942 |
Price to Book Value Related Metrics
| Price | 1.27 |
| Earnings Yield | -15.99% |
| Market Cap | 80.53M |